Showing results (191-200 of 293) with videos related to
Sort By:
Pageof 30
Journal of Neuro-Oncology|February 28, 2023
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymomaKathryn R Tringale, Suzanne L Wolden, Matthias Karajannis, et al.International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
Proceedings of the ASTRO-RSNA Oligometastatic Disease Research WorkshopJames B Yu, Kristy K Brock, Allison M Campbell, et al.Pediatric Blood & Cancer|January 17, 2009
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.International Journal of Cancer|February 11, 2026
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remissionBrian H Kushner, Shakeel Modak, Charlie White, et al.International Journal of Cancer|January 10, 2026
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remissionBrian H Kushner, Charlie White, Audrey Mauguen, et al.Oncoimmunology|July 4, 2015
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub> immunotherapy and isotretinoin: a prospective Phase II studyBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9Shakeel Modak, Hong Fen Guo, John L Humm, et al.International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Christopher A Barker, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2019
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trialMichael J Morris, Yohann Loriot, Christopher J Sweeney, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 16, 2025
Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical ImplementationSergios Gatidis, Maria Rosana Ponisio, Lise Borgwardt, et al.Pageof 30